ACN Form 4: Alan Jope Granted 1,978 Shares via RSU Anti-Dilution
Rhea-AI Filing Summary
Alan C. Jope, a director of Accenture plc (ACN), reported an acquisition of 1,978 Class A ordinary shares on 08/15/2025. The shares were received as a grant of Restricted Share Units (RSUs) under anti-dilution provisions tied to a cash dividend; the report shows a deemed price of $247.57 per share. Following the transaction, Mr. Jope beneficially owns 1,978 shares directly. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses a routine equity award adjustment rather than an open-market trade.
Positive
- Director increased direct ownership by 1,978 Class A ordinary shares via RSU grant, improving alignment with shareholders
Negative
- None.
Insights
TL;DR: Routine RSU anti-dilution adjustment increased the director's direct holdings by 1,978 shares; procedural disclosure only.
This Form 4 documents a non-market acquisition of shares via RSU anti-dilution provisions tied to a dividend payment. Such adjustments preserve the economic value of prior equity awards when dividends are paid. The filing is standard governance practice and provides transparency on director ownership. No sale, new compensation plan, or change in control is evident from the form.
TL;DR: Director received 1,978 RSUs at an implied price of $247.57; impact on float and insider position is immaterial.
The disclosure shows an acquisition of 1,978 Class A ordinary shares via RSU anti-dilution on 08/15/2025 at an implied value of $247.57 per share. This is an equity compensation accounting adjustment rather than a purchase or sale on the open market. The change in beneficial ownership is modest relative to Accenture's market capitalization and does not indicate directional insider trading activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A ordinary shares | 6 | $247.57 | $1K |
Footnotes (1)
- [object Object]